We developed an inhibitor of the SOD1–Derlin-1(CT4) interaction that ameliorates ALS pathology in patient-derived induced pluripotent stem cell–derived motor neurons harboring an SOD1 mutation and in an ALS mouse model expressing a human SOD1 G93A mutant [15]. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.